Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
Xiaoqi Yu, Dong Wei, Wenxin Xu, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review
Santenna Chenchula, Padmavathi Karunakaran, Sushil Sharma, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2969-2976
Open Access | Times Cited: 301
Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic
Rekha Khandia, Shailja Singhal, Taha Alqahtani, et al.
Environmental Research (2022) Vol. 209, pp. 112816-112816
Open Access | Times Cited: 283
Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas
Paul Christensen, Randall J. Olsen, Sheng Long, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 4, pp. 642-652
Open Access | Times Cited: 203
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 103
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 97
Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
Bo Gao, Liheng He, Yu-Jie Bao, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 258-261
Open Access | Times Cited: 54
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 69
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 68
The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 591-591
Open Access | Times Cited: 65
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore
Oon Tek Ng, Kalisvar Marimuthu, Nigel Wei-Han Lim, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2228900-e2228900
Open Access | Times Cited: 63
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
Mohammad Alkhatib, Romina Salpini, Luca Carioti, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 2
Open Access | Times Cited: 54
Immune Escape Associated with RBD Omicron Mutations and SARS-CoV-2 Evolution Dynamics
Aleksandr V. Kudriavtsev, Anna Vakhrusheva, Valery Novoseletsky, et al.
Viruses (2022) Vol. 14, Iss. 8, pp. 1603-1603
Open Access | Times Cited: 46
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection
H. J. Yang, Weiqi Hong, Lei Hong, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 39
Ferroptosis and tumor immunotherapy: A promising combination therapy for tumors
Huazhong Cai, Yongfei Ren, Shuangwei Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 38
Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses
Chang Yi Wang, Wen‐Jiun Peng, Be-Sheng Kuo, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1010870-e1010870
Open Access | Times Cited: 27
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies
Nathan J. Cheetham, Milla Kibble, Andrew Wong, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 25
Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy
Zsolt Matula, Márton Gönczi, Gabriella Bekő, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 539-539
Open Access | Times Cited: 32
Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection
Endeshaw Chekol Abebe, Markeshaw Tiruneh G Medhin, Awgichew Behaile T Mariam, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 1871-1887
Open Access | Times Cited: 30
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 20
Neutralizing potency of COVID‐19 vaccines against the SARS‐CoV‐2 Omicron (B.1.1.529) variant
Giuseppe Lippi, Camilla Mattiuzzi, Brandon Michael Henry
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1799-1802
Open Access | Times Cited: 28
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
Ailan Xu, Bixia Hong, Fuxing Lou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 25
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 years
Enagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.
The Lancet Regional Health - Europe (2022) Vol. 17, pp. 100385-100385
Open Access | Times Cited: 23
Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
Sara Khaleeq, Nayanika Sengupta, Sahil Kumar, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 346-346
Open Access | Times Cited: 16
Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
Luxin Li, Yucen Dai, Dan Ke, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top